Prostate cancer, Pathology, Prostate, Prostatectomy and Internal medicine are his primary areas of study. Prostate cancer is a subfield of Cancer that Lars Egevad explores. His work carried out in the field of Pathology brings together such families of science as Consensus conference and High-grade prostatic intraepithelial neoplasia.
His Prostate study integrates concerns from other disciplines, such as Tumor progression, Angiogenesis, Metastasis and Adenocarcinoma. He has researched Prostatectomy in several fields, including Proportional hazards model, Surgical pathology, Radiation therapy and Anatomical pathology. His Internal medicine research includes themes of Endocrinology, Surgery and Oncology.
Lars Egevad focuses on Prostate cancer, Pathology, Prostate, Internal medicine and Prostatectomy. Prostate cancer is the subject of his research, which falls under Cancer. His Pathology study frequently involves adjacent topics like Adenocarcinoma.
His study looks at the relationship between Prostate and fields such as Gynecology, as well as how they intersect with chemical problems. His Internal medicine study combines topics in areas such as Endocrinology and Oncology. His Prostatectomy study incorporates themes from Surgery, Proportional hazards model and Lymph node.
Lars Egevad spends much of his time researching Prostate cancer, Pathology, Prostate, Grading and Cancer. His biological study focuses on Prostatectomy. He focuses mostly in the field of Pathology, narrowing it down to matters related to Molecular pathology and, in some cases, Penile cancer, Urogenital cancer, Androgen receptor, Ki-67 and DNA mismatch repair.
His research in Prostate intersects with topics in Carcinoma, MEDLINE, Medical physics and Perineural invasion. His Grading research also works with subjects such as
Lars Egevad mainly investigates Prostate cancer, Pathology, Grading, Prostate and Molecular pathology. He does research in Prostate cancer, focusing on Prostatectomy specifically. Within one scientific family, Lars Egevad focuses on topics pertaining to Consensus conference under Prostatectomy, and may sometimes address concerns connected to Medical physics, Prostate carcinoma, Gleason Score 6, Gleason grade and Gleason grading system.
His study on Disease, Immunohistochemistry and Clear cell is often connected to Low resource as part of broader study in Pathology. Lars Egevad combines subjects such as Biopsy and Ai systems, Artificial intelligence with his study of Grading. In his study, Invasive carcinoma is inextricably linked to Carcinoma, which falls within the broad field of Prostate.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma
Geert J.L.H. van Leenders;Theodorus H. van der Kwast;David J. Grignon;Andrew J. Evans.
The American Journal of Surgical Pathology (2005)
The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.
Jonathan I. Epstein;Lars Egevad;Mahul B. Amin;Brett Delahunt.
The American Journal of Surgical Pathology (2015)
International network of cancer genome projects
Thomas J. Hudson;Thomas J. Hudson;Warwick Anderson;Axel Aretz;Anna D. Barker.
Gene expression profiling identifies clinically relevant subtypes of prostate cancer
Jacques Lapointe;Chunde Li;John P. Higgins;Matt van de Rijn.
Proceedings of the National Academy of Sciences of the United States of America (2004)
A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score.
Jonathan I. Epstein;Michael J. Zelefsky;Daniel D. Sjoberg;Joel B. Nelson.
European Urology (2016)
The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasia
John R. Srigley;Brett Delahunt;John N. Eble;Lars Egevad.
The American Journal of Surgical Pathology (2013)
The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic Parameters
Brett Delahunt;John C. Cheville;Guido Martignoni;Peter A. Humphrey.
The American Journal of Surgical Pathology (2013)
The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer
M. Norberg;L. Egevad;L. Holmberg;P. Sparén.
CD4+CD25high T Cells Are Enriched in the Tumor and Peripheral Blood of Prostate Cancer Patients
Ashley M. Miller;Kajsa Lundberg;Volkan Özenci;Alison H. Banham.
Journal of Immunology (2006)
Tumor associated macrophages in human prostate cancer: relation to clinicopathological variables and survival
I F Lissbrant;P Stattin;P Wikstrom;J E Damber.
International Journal of Oncology (2000)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: